drugset / Trial / NCT03239236

Modified Rapid Sequence Induction in Morbidly Obese Patients

NCT03239236

RandomizedParallel-groupSingle-blindTreatment

Summary

This study investigates the effect of 4 different methods of rapid sequence induction (RSI) in morbidly obese patients on the amount of air insufflation into the stomach.

Timeline

Start
2021-02
Primary completion
2021-02
Completion
2021-02

Drugs

EvaluationDrugModalityDoseRoute
Background Fentanyl Other / unclassified 250 ug
Background Propofol Small molecule 2.5 mg/kg
Background Rocuronium Other / unclassified 1.2 mg/kg

Indications

No indication recorded.